{"count": 5, "results": [{"_id": "33213791", "pmid": 33213791, "title": "Current Status of Chemoprevention in Barrett's Esophagus.", "journal": "Gastrointest Endosc Clin N Am", "authors": ["Moayyedi P", "El-Serag HB"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.giec.2020.08.008", "meta_date_publication": "2021 Jan", "meta_volume": "31", "meta_issue": "1", "meta_pages": "117-130", "score": 50268.18, "text_hl": "Candidates for chemoprevention in @<m>DISEASE_Barrett_Esophagus</m> @DISEASE_MESH:D001471 @@@Barrett's esophagus@@@ have long been suggested and there has been observational data to support many drugs, including statins, hormone replacement therapy, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, proton pump inhibitor therapy, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@. ", "citations": {"NLM": "Moayyedi P, El-Serag HB. Current Status of Chemoprevention in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan;31(1):117-130. PMID: 33213791", "BibTeX": "@article{33213791, title={Current Status of Chemoprevention in Barrett's Esophagus.}, author={Moayyedi P and El-Serag HB}, journal={Gastrointest Endosc Clin N Am}, volume={31}, number={1}, pages={117-130}}"}}, {"_id": "34398301", "pmid": 34398301, "pmcid": "PMC8921146", "title": "Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis", "journal": "Cancer Immunol Immunother", "authors": ["Takei R", "Miyashita T", "Takada S", "Tajima H", "Ninomiya I", "Takamura H", "Fushida S", "Harashima A", "Munesue S", "Yagi S", "Inaki N", "Ohta T", "Yamamoto Y"], "date": "2022-04-01T00:00:00Z", "doi": "10.1007/s00262-021-03027-x", "meta_date_publication": "2022 Apr", "meta_volume": "71", "meta_issue": "4", "meta_pages": "777-789", "score": 50261.668, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment inhibits development of @<m>DISEASE_Barrett_Esophagus</m> @DISEASE_MESH:D001471 @@@BE@@@ and @DISEASE_Esophageal_Neoplasms @DISEASE_MESH:D004938 @@@EC@@@", "citations": {"NLM": "Takei R, Miyashita T, Takada S, Tajima H, Ninomiya I, Takamura H, Fushida S, Harashima A, Munesue S, Yagi S, Inaki N, Ohta T, Yamamoto Y. Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis Cancer Immunol Immunother. 2022 Apr;71(4):777-789. PMID: 34398301", "BibTeX": "@article{34398301, title={Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis}, author={Takei R and Miyashita T and Takada S and Tajima H and Ninomiya I and Takamura H and Fushida S and Harashima A and Munesue S and Yagi S and Inaki N and Ohta T and Yamamoto Y}, journal={Cancer Immunol Immunother}, volume={71}, number={4}, pages={777-789}}"}}, {"_id": "32998939", "pmid": 32998939, "title": "Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.", "journal": "Cancer Prev Res (Phila)", "authors": ["Loomans-Kropp HA", "Chaloux M", "Richmond E", "Umar A"], "date": "2021-02-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-20-0274", "meta_date_publication": "2021 Feb", "meta_volume": "14", "meta_issue": "2", "meta_pages": "195-204", "score": 50261.145, "text_hl": "Use of PPIs alone and with NSAIDs, statins, or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was associated with reduced risk of @DISEASE_Adenocarcinoma @DISEASE_MESH:D000230 @@@EAC@@@; however, a history of @<m>DISEASE_Barrett_Esophagus</m> @DISEASE_MESH:D001471 @@@BE@@@ may diminish drug efficacy. ", "citations": {"NLM": "Loomans-Kropp HA, Chaloux M, Richmond E, Umar A. Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis. Cancer Prev Res (Phila). 2021 Feb;14(2):195-204. PMID: 32998939", "BibTeX": "@article{32998939, title={Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.}, author={Loomans-Kropp HA and Chaloux M and Richmond E and Umar A}, journal={Cancer Prev Res (Phila)}, volume={14}, number={2}, pages={195-204}}"}}, {"_id": "35203241", "pmid": 35203241, "pmcid": "PMC8869996", "title": "Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis", "journal": "Cells", "authors": ["Olivier S", "Diounou H", "Pochard C", "Frechin L", "Durieu E", "Foretz M", "Neunlist M", "Rolli-Derkinderen M", "Viollet B"], "date": "2022-02-09T00:00:00Z", "doi": "10.3390/cells11040590", "meta_date_publication": "2022 Feb 9", "meta_volume": "11", "meta_issue": "4", "meta_pages": "", "score": 50250.867, "text_hl": "We also tested the hypothesis that protection mediated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration on intestinal @<m>DISEASE_Barrett_Esophagus</m> @DISEASE_MESH:D001471 @@@epithelium damage@@@ required @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activation. ", "citations": {"NLM": "Olivier S, Diounou H, Pochard C, Frechin L, Durieu E, Foretz M, Neunlist M, Rolli-Derkinderen M, Viollet B. Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis Cells. 2022 Feb 9;11(4):. PMID: 35203241", "BibTeX": "@article{35203241, title={Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis}, author={Olivier S and Diounou H and Pochard C and Frechin L and Durieu E and Foretz M and Neunlist M and Rolli-Derkinderen M and Viollet B}, journal={Cells}, volume={11}, number={4}}"}}, {"_id": "25218668", "pmid": 25218668, "title": "Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.", "journal": "Clin Gastroenterol Hepatol", "authors": ["Chak A", "Buttar NS", "Foster NR", "Seisler DK", "Marcon NE", "Schoen R", "Cruz-Correa MR", "Falk GW", "Sharma P", "Hur C", "Katzka DA", "Rodriguez LM", "Richmond E", "Sharma AN", "Smyrk TC", "Mandrekar SJ", "Limburg PJ", "Cancer Prevention Network"], "date": "2015-04-01T00:00:00Z", "doi": "10.1016/j.cgh.2014.08.040", "meta_date_publication": "2015 Apr", "meta_volume": "13", "meta_issue": "4", "meta_pages": "665-72.e1-4", "score": 50068.68, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ does not reduce markers of cell proliferation in esophageal tissues of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Barrett_Esophagus</m> @DISEASE_MESH:D001471 @@@Barrett's esophagus@@@.", "citations": {"NLM": "Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ, Cancer Prevention Network. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Apr;13(4):665-72.e1-4. PMID: 25218668", "BibTeX": "@article{25218668, title={Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.}, author={Chak A and Buttar NS and Foster NR and Seisler DK and Marcon NE and Schoen R and Cruz-Correa MR and Falk GW and Sharma P and Hur C and Katzka DA and Rodriguez LM and Richmond E and Sharma AN and Smyrk TC and Mandrekar SJ and Limburg PJ and Cancer Prevention Network}, journal={Clin Gastroenterol Hepatol}, volume={13}, number={4}, pages={665-72.e1-4}}"}}]}